CFDE Data Portal | Search FAM238A

	Label	Description
	FAM238A Gene (Entity type)	ENSG00000290444 - family with sequence similarity 238 member A
	GSE128255 NDP knockdown stem cell 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 hydroxychloroquine 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 6 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	SCNN1D IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GPR89A IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE155800 imatinib 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Prostate 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx AdrenalGland 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Blood 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx

FAM238A

ENSG00000290444 - family with sequence similarity 238 member A

GSE128255 NDP knockdown stem cell 3 v 0 human up

A Gene Set from LINCS

GSE159678 hydroxychloroquine 6 v 7 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 6 v 3 human up

A Gene Set from LINCS

SCNN1D IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

GPR89A IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

GSE155800 imatinib 1 v 0 human dn

A Gene Set from LINCS

GTEx Prostate 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx AdrenalGland 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Blood 20-29 vs 70-79 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.